About

NEWS

KYTHERA® Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat August 18, 2015

more

KYTHERA on Twitter

Join us
@KytheraBiopharmaceuticals

Follow us on Twitter